INTRODUCTION {#sec1-1}
============

Around 5000 years ago, *Polygonatum* species has been practiced in Chinese and European health-care system. *Polygonatum verticillatum* is a flowering perennial plant of the family *Liliaceae* and is commonly known as Mahameda in Hindi and Whorled Solomon\'s Seal in English. Mahameda is a deciduous, erect plant of *Polygonatum* genus having bell-shaped greenish-white flowers, mid-green leaves, and red fruits. In India, Mahameda is found in temperate Himalayas from Kashmir (at an altitude of 2000--3600 m asl) to Sikkim (at an altitude of 2600--4000 m asl), Himachal Pradesh and Uttarakhand (1600--3500 m asl). Mahameda is a vital ingredient of Ashtawarga group and numerous Ayurvedic formulations such as Chyawanprash, Vachadi Taila, Astavarga Churna, Chitrakadi Taila, Mahakalyan Ghrita, Mahamayura Ghrita, Mahapadma Taila, Jivaniya Ghrita, Brahini Gutika, Vajikaran Ghrita, Indrokta Rasayan, etc.\[[@ref1]\] Due to extensive usage, the demand of Mahameda is progressively increasing which leads to large scale and indiscriminate collection of wild material and ultimately to scarcity of the authentic source. Currently, Mahameda comes under the category of endangered plants.\[[@ref2][@ref3]\]

To meet out the market pressure and to overcome the scarcity, substitutes of Mahameda and other Ashtawarga plants are commonly in use. Mahameda has been officially substituted by Shatavari,\[[@ref4]\] which in turn is substituted by Shakakul Mishri. However, Mahameda has different chemical constituents, pharmacological actions, and Ayurvedic parameters of drug action from its substitutes. This situation directly leads to substitution/adulteration, resulting in further decline of cultivation of Mahameda and other rare plants.\[[@ref2][@ref5]\] Thus, it is a critical issue to identify and isolate the therapeutically active ingredients of Mahameda that can be used as markers for the identification of unauthorized substitution/adulteration.

Traditionally, Mahameda is known to be effective against emaciation, senility, pain, pyrexia, weakness, burning sensation, phthisis, and pulmonary affections and also has other significant effects such as tonic, galactagogue, emollient, aphrodisiac, insecticidal, and leishmanicidal.\[[@ref2]\] Therapeutic actions of Mahameda are mainly due to the presence of steroidal saponins and polysaccharides in the rhizome.\[[@ref3]\] Rhizomes of Mahameda have been proven for anti-oxidant,\[[@ref6]\] antispasmodic, antidiarrheal,\[[@ref7]\] antipyretic,\[[@ref8]\] tracheorelaxant, anti-inflammatory,\[[@ref9]\] antimicrobial,\[[@ref10]\] antinociceptive, diuretic,\[[@ref11]\] and antimalarial potential.\[[@ref12]\] Rhizomes of Mahameda are known to contain phytoconstituents such as lysine, serine, aspartic acid, threonine, diosgenin, β-sitosterol, sucrose, glucose,\[[@ref1]\] micronutrients (Zn, Fe, Pb, Cu, Ni, Cd, Cr, Co, Sb and Mn), macronutrients (Na, Ca, and K), and essential life nutrients (proteins, fats, carbohydrates, and ascorbic acid).\[[@ref13]\] Few compounds have been isolated from the rhizomes of *P. verticillatum* which include lectins,\[[@ref14]\] 5-hydroxymethyl-2-furaldehyde,\[[@ref12]\] diosgenin, santonin,\[[@ref6]\] 2-hydroxybenzoic acid, and β-sitosterol.\[[@ref9]\] The present study was designed to isolate and identify other important phytoconstituents of Mahameda, to assist as markers in identifying adulteration.

MATERIALS AND METHODS {#sec1-2}
=====================

Plant material {#sec2-1}
--------------

Rhizomes of *P. verticillatum* were collected from Himachal Pradesh, India from a cultivated source in August-September 2014 and authenticated by the cultivator vide letter number no. HRG/Testimonial-NMPB/02/2015-2016. Further authentication of the plant material was done at the Central Instrumentation Facility, National Botanical Research Institute, Lucknow, India vide Ref. No: NBRI/CIF/524/2016. The plant material was shade dried (\<40°C), coarsely powdered, and stored in an air tight container.

Chemicals {#sec2-2}
---------

All the chemicals and reagents used during the study were of analytical grade and were purchased from different companies such as Qualikems, Finar, and Merck. Infrared (IR) was recorded on a PerkinElmer Fourier transmission infrared, and nuclear magnetic resonance (NMR) spectra were recorded using CDCl~3~ as solvent on Bruker Avance II 400 NMR spectrometer at Panjab University, Chandigarh, and ultraviolet (UV) spectra were recorded on a high-resolution UV-visible spectrometer.

Extraction of *Polygonatum verticillatum* {#sec2-3}
-----------------------------------------

Coarsely powdered rhizomes of *P. verticillatum* were first defatted with petroleum ether and then extracted with methanol, by continuous hot extraction process using a Soxhlet apparatus. The extract was filtered and concentrated by distillation to obtain a semi-solid mass and percentage yield was calculated. The extract was kept in a desiccator for further use.

Phytochemical screening of extract {#sec2-4}
----------------------------------

The extract of *P. verticillatum* was subjected to preliminary phytochemical screening for the detection of various phytoconstituents, namely, alkaloids, glycosides, steroids, terpenoids, anthraquinone flavonoids, tannins, phenolic compounds, saponins, carbohydrates, proteins, and amino acids,\[[@ref15][@ref16]\] as given in [Table 1](#T1){ref-type="table"}.
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Isolation of marker compound {#sec2-5}
----------------------------

The extract was subjected to column chromatography for the isolation purpose.\[[@ref17]\]

### Preparation of slurry {#sec3-1}

Rhizome extract (8.5 g) of the plant was dissolved in a minimum amount of methanol, and sufficient quantity of silica gel (60--120 mesh size/0.120--0.250 mm particle size) was added, with trituration, for uniform mixing. After appropriate mixing, the slurry was dried on a water bath to get a free flowing material.

### Packing of column (wet packing) {#sec3-2}

680g of silica gel (0.120--0.250 mm particle size) was suspended in hexane and poured into the glass column (60 × 40). After saturation of the bed, drug slurry was loaded into the column, and the column was allowed to stand overnight for uniform bed packing.

### Elution of column {#sec3-3}

Column was first eluted with pure hexane and polarity of the solvent was increased gradually by adding chloroform (9:1, 8:2, 7:3, 6:4, 1:1, 4:6, 3:7, 2:8, and 1:9) to pure chloroform, followed by ethyl acetate-methanol to pure methanol, further followed by increasing amount of methanol in the same manner. A total of 1180 fractions, each of 100 ml, were collected with flow rate of 4 ml/minute, as per prescribed standard flow rate. Mobile phase for thin-layer chromatography (TLC) was standardized by hit and trial method, and TLC was performed using solvent system having different polarity. Fractions having similar TLC profiles were pooled to give the major fraction. A total of 58 pooled subfractions were collected from the column. A white-colored crystalline compound was obtained from the fractions numbered 830-965. Purification of the isolated compound was done by recrystallization through methanol. The fractions were kept in a refrigerator to get the crystallized compound. Confirmatory analysis was carried out through chemical tests, melting point, ^1^H-NMR, ^13^C-NMR and compared with literature.

Characterization of isolated compound {#sec2-6}
-------------------------------------

### Chemical tests {#sec3-4}

The extract was treated with a few ml of dilute HCl, filtered, and subjected to the following tests:

### Dragendorff\'s reagent test {#sec3-5}

To 2--3 ml of filtrate, 0.5 ml of Dragendorff\'s reagent was added. Formation of orange-brown precipitate revealed the positive test for alkaloids.

### Mayer\'s reagent test {#sec3-6}

To 2--3 ml filtrate, 0.5 ml of Mayer\'s reagent was added; formation of a cream-colored precipitates revealed the positive test for alkaloids.

### Melting point {#sec3-7}

The melting point of the crystallized compound was determined using a melting point apparatus.

### Spectral analysis {#sec3-8}

Different spectroscopic techniques such as IR, NMR, mass, and UV spectral analysis were used to identify the structure of the isolated compound.

### Thin-layer chromatography of isolated compound with extract {#sec3-9}

The aim of thin-layer chromatographic study was to develop such a method which can separate the marker of the extract. Out of tried mobile phases, n-Hexane: ethyl acetate (4:6 v/v) showed the best separation of the isolated compound in the extract.

RESULTS {#sec1-3}
=======

Physical evaluation of extract {#sec2-7}
------------------------------

A dark brown-colored semi-solid mass was obtained, and the percent yield was found to be 14% (w/w).

Phytochemical screening of extract {#sec2-8}
----------------------------------

Phytochemical screening of the extract is shown in [Table 1](#T1){ref-type="table"}, which indicated the presence of various phytoconstituents.

Identification of isolated compound {#sec2-9}
-----------------------------------

### Physicochemical characterization {#sec3-10}

The isolated compound was found as a white crystalline powder, having a percent yield of 0.015% and the melting point in the range of 173°C--175°C, which was similar to that of the melting point of standard Quinine (174°C--175°C).

### Chemical test {#sec3-11}

The isolated compound showed positive test of flavonoids and alkaloids.

### Spectral analysis {#sec3-12}

**Infrared of isolated compound**

The IR spectra (KBr) (n/cm) show the peaks at -- 3206.22 O-H str (H-bonded), 2967.03-2901.27 C-H str (alkane, alkene, aromatic), 1620-1432 C = C str (aromatic, alkene), 1473-1432 CH~2~ bend (alkane, cycloalkane), 1299-1358 C-N str (cyclic amine), 1243-1080 C-O str (ether), 1080-1009 C-O str (alcohol), 980-575 = C-H bend (out of plane), and 780-718 CH~2~ bend-rocking type (alkane). These characteristic peaks confirm the presence of Quinine skeleton in the molecule \[[Figure 1](#F1){ref-type="fig"}\].

![Infrared spectrum of the isolated compound](JAPTR-7-153-g002){#F1}

**^1^H-nuclear magnetic resonance spectrum**

^1^H NMR (CDCl~3~, 400 MHz) d in ppm: 0.00 (TMS proton), 1.24-1.30 (CH~2~ of azabicyclo ring), 2.00-2.04 (CH~2~ of piperidine ring), 1.60 (-C-O-H), 3.94 (ether -O-CH3), 4.96-5.11 (=CH2), 6.99-7.89 (isoquinoline). Obtained data \[[Figure 2](#F2){ref-type="fig"}\] clearly signify the presence of Quinine as the isolated compound.

![Nuclear magnetic resonance spectrum of the isolated compound](JAPTR-7-153-g003){#F2}

**Mass spectrum**

The mass spectra of the isolated compound (LC-MS) showed remarkable peaks at (m/z): 136.20 (99.99%), 189.10 (6.26%), 117.10 (5.7%), 79.10 (4.1%), and 324.41 (1.3%, M^+^). These details are in agreement with the proposed structure and strictly comply with the mass spectrum of standard Quinine \[[Figure 3](#F3){ref-type="fig"}\].

![Mass spectrum of the isolated compound](JAPTR-7-153-g004){#F3}

**Ultravilot spectrum**

The UV spectra of the isolated compound showed wavelength of maximum absorbance (λ~max~) at 265 and 298 in ethyl acetate and methanol, respectively \[[Table 2](#T2){ref-type="table"}\].
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### Thin-layer chromatography chromatogram {#sec3-13}

**Thin-layer chromatography chromatogram of extract and isolated compound**

The TLC chromatogram of the extract and the isolated compound are shown in [Figure 4](#F4){ref-type="fig"}, and the R~f~ value of the isolated compound was found to be 0.6. In addition, the two-dimensional-TLC chromatogram of the isolated compound is shown in [Figure 5](#F5){ref-type="fig"}.

![Thin-layer chromatography chromatogram of the extract and isolated compound](JAPTR-7-153-g006){#F4}

![2-D TLC of isolated compound](JAPTR-7-153-g007){#F5}

### Structure and molecular formula of isolated compound {#sec3-14}

The molecular formula of the isolated compound is C~20~ H~24~ N~2~ O~2~ which further confirmed it as Quinine (yield = 0.147%), i.e., 6-methoxyquinolin-4-yl-8-vinylquinuclidin-2-yl-methanol, through the physicochemical and spectral data available in the literature. The structure of the stated compound is given in [Figure 6](#F6){ref-type="fig"}.

![Structure of the isolated compound](JAPTR-7-153-g008){#F6}

DISCUSSION AND CONCLUSION {#sec1-4}
=========================

Quinine is one of the oldest alkaloids and is mainly found in the bark of *Cinchona* genus.\[[@ref18]\] It is chiefly used in the treatment of malaria caused by *Plasmodium falciparum* that is resistant to other antimalarials. Quinine is also used as antibacterial, antiseptic, antipyretic, mild oxytocic, local anesthetic, cardiovascular protectant, and analgesic, etc. Quinine is used in lotions and in tonic beverages that are mixed with alcohols for bitter taste.\[[@ref15][@ref19]\] Because of broad spectrum usage, it is a very valuable compound that has been isolated from *P. verticillatum*. It is a rare plant and comes under the category of endangered plants, and there is always a possibility of adulteration in the plant material. The identification of substitution/adulteration on the basis of therapeutically active ingredients such as Quinine as the marker shall be very useful. Till date, Quinine is the identification parameter of *Cinchona* bark and this study establishes it to be used for *P. verticillatum*. The market price of Quinine is very high, and it will be difficult for commercial organizations to substitute the Mahameda plant with Quinine, just to claim the presence of Mahameda. However, if equivalent amount of Mahameda is added, it will be cheaper for the industry, in addition to its original status as a drug. Thus, Quinine can be an excellent marker for the identification of substitution/adulteration in *P. verticillatum*.

In the present study, the Quinine was isolated from rhizomes of *P. verticillatum*. The compound was confirmed by chemical tests, melting point, UV, IR, NMR, and mass spectroscopy. To the best of our knowledge, this is first report on the isolation of Quinine from *P. verticillatum*. It is further concluded that it can also be used as a supplement marker for *P. verticillatum* as the cost of the isolated compound is very high to be used as a substituent/adulterant in the *P. verticillatum* plant material. This shall provide an effective means for the standardization of the plant *P. verticillatum*.
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